Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
JCSE01 - Joint IASLC-CSCO-CAALC Session
- 07:00 - 11:15
- 9/07/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Joint IASLC-CSCO-CAALC Session
- Track:
- Moderators:Chunxue Bai, Tony Mok, Yi-Long Wu, Qing Zhou, Nan Wu
-
+
JCSE01.23 - Specific TP53 Mutation Subtypes as Biomarker for Response to PD-1/L1 Blockade Immunotherapy in NSCLC
10:45 - 10:45 | Presenter: Hao Sun | Author(s): Si-yang Liu, Jia Ying Zhou, Meimei Zheng, Jiao Jiao Huan, Yan Fang Guan, Rui Gao, Xin Yi, Yi-Long Wu
- Abstract
Loading... -
+
JCSE01.28 - Changes of Brain Structure in Advanced NSCLC Patients Receiving EGFR-TKIs: Dynamic Analysis Based on Series MRI Images
10:45 - 10:45 | Presenter: Chunli Luo | Author(s): Beisheng Yang, Xiaojuan Zhou, Lin Zhou, Ying Zhou, Jiang Zhu, Meijuan Huang, Feng Peng, Yongmei Liu, Yongsheng Wang, Zhiping Li, You Lu, Su Lui, Youling Gong
- Abstract
Loading...
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.03 - The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
10:50 - 11:00 | Presenter: Shun Lu | Author(s): Qiming Wang, Guojun Zhang, Xiaorong Dong, Cheng-Ta Yang, Yong Song, Gee-Chen Chang, You Lu, Hongming Pan, Chao-Hua Chiu, Zhehai Wang, Jifeng Feng, Jianying Zhou, Xingxiang Xu, Renhua Guo, Jianhua Chen, Haihua Yang, Yuan Chen, Zhuang Yu, Her-Shyong Shiah, Chin-Chou Wang, Nong Yang, Jian Fang, Ping Wang, Kai Wang, Yanping Hu, Jianxing He, Ziping Wang, Jianhua Shi, Shaoshui Chen, Ying Cheng, Wu-Chou Su, Te-Chun Hsia, Jiuwei Cui, yuping Sun, Chih-Hsin Yang
- Abstract
Loading...
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.09 - Long-Term Outcomes to Tepotinib Plus Gefitinib in Patients with EGFR-Mutant NSCLC and MET Dysregulation: 18‑Month Follow-Up
16:15 - 16:20 | Presenter: Yi-Long Wu | Author(s): Ying Cheng, Jianying Zhou, Shun Lu, Yiping Zhang, Jun Zhao, Dong-Wan Kim, Ross Soo, Sang-we Kim, Hongming Pan, Yuh-Min Chen, Chih-Feng Chian, Xiaoqing Liu, Daniel SW Tan, Rolf Bruns, Josef Straub, Andreas Johne, Jürgen Scheele, Keunchil Park, James Chih-Hsin Yang
- Abstract
Loading...
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.03 - A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
15:35 - 15:45 | Presenter: Caicun Zhou | Author(s): Gongyan Chen, yunchao Huang, Jianying Zhou, LiZhu Lin, Jifeng Feng, Zhehai Wang, Yongqian Shu, Jianhua Shi, Yi Hu, Qiming Wang, Ying Cheng, Jianhua Chen, Xiaoyan Lin, Yongsheng Wang, Jianan Huang, Jiuwei Cui, Lejie Cao, Yunpeng Liu, Yiping Zhang, Yueyin Pan, Jun Zhao, LiPing Wang, Jianhua Chang, Qun Chen, Xiubao Ren, Wei Zhang, Yun Fan, Zhiyong He, Jian Fang, Kangsheng Gu, Xiaorong Dong, Faguang Jin, Hongjun Gao, Guangyu An, Cuimin Ding, Xiaodong Jiang, Jianping Xiong, Xiangdong Zhou, Sheng Hu, Ping Lu, Anwen Liu, Shuliang Guo, Jianjin Huang, Chengchu Zhu, Jian Zhao, Beili Gao, Yinglan Chen, Chengping Hu, Jian Zhang, Hongmei Zhang, Hui Zhao, Yujie Zhou, Yanfei Tai
- Abstract
Loading...
-
+
EP1.14 - Targeted Therapy
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
EP1.14-52 - Variants Distribution and Clinical Outcomes to Crizotinib According to Molecular Features in ALK-Rearranged NSCLCs
08:00 - 08:00 | Presenter: Jianying Zhou | Author(s): Jianya Zhou, Jing Zheng, Yanping Zhu, Qian Shen, Yuehong Wang, He Cao, Xuejing Guo, Wenjia Sun, Tengfei Zhang, Jing Lin, Bing Yu
- Abstract
No abstract available for this presentation
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-106 - Clinical Features and Tumor Immune Microenvironment Related to Acquired Resistance to EGFR-TKI in NSCLC Patients with EGFR Mutation
09:45 - 09:45 | Presenter: Pei Zhang | Author(s): Lingfang Tu, Rong Liu, Xuanli Xu, Zhang Bao, Panfeng Xu, Jie Wang, Hequan Li, Jianying Zhou, Yuehong Wang
- Abstract
Loading... -
+
P1.01-36 - Clinical Potential of Tissue Tumor Mutational Burden (tTMB) and Blood TMB (bTMB) as a Biomarker in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Jianying Zhou | Author(s): Jianya Zhou, Xi Chen, Yanping Zhu, Liangjie Fang, Zhang Bao, Rong Liu, He Cao, Wenjia Sun, Tengfei Zhang, Jing Lin, Bing Yu
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-37 - Dioscin Elicits Anti-Tumor Immunity by Inhibiting Macrophages M2 Polarization via JNK and STAT3 Pathways in Lung Cancer
09:45 - 09:45 | Presenter: Yinan Yao | Author(s): Luyun Cui, Jiani Ye, Jianying Zhou
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-31 - Lack of Association Between BIM Deletion Polymorphism and Clinical Efficacy of EGFR-TKIs in NSCLC Based on NGS
09:45 - 09:45 | Presenter: Si-Yang Liu | Author(s): Wen-Feng Li, Hao Sun, Yi-Chen Zhang, Jia-Ying Zhou, Jin-Ji Yang, Yi-Long Wu
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.02 - KEYNOTE-042 China Study: First-Line Pembrolizumab vs Chemotherapy in Chinese Patients with Advanced NSCLC with PD-L1 TPS ≥1%
14:05 - 14:10 | Presenter: Yi-Long Wu | Author(s): Li Zhang, Yun Fan, Jianying Zhou, Li Zhang, Qing Zhou, Wei Li, ChengPing Hu, Gongyan Chen, Xin Zhang, Caicun Zhou, Thao Dang, Justina Penrod, Debra A. Kush, Yun Qin, Ben Li, Tony Mok
- Abstract
Loading... -
+
MA11.06 - A PII Study of Toripalimab, a PD-1 mAb, in Combination with Chemotherapy in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies
14:35 - 14:40 | Presenter: Jie Zhang | Author(s): Caicun Zhou, yanqiu Zhao, Xiaoqian Mu, Jianying Zhou, Zhang Bao, Yun Fan, Yanjun Xu, Yongqian Yong Shu, Renhua Guo, Xiaoqing Liu, Hong Wang, Helong Zhang, Lin Deng, Ningqiang Ma, Jianxing He, Yalei Zhang, mo Chen, Yinrui Jiang
- Abstract
Loading...
-
+
OA11 - Decomplexifying Molecular Targets, Immunotherapy and Treatment Settings in the Real World
- 14:00 - 15:30
- 9/09/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Moderators:Kumar Prabhash, Jyoti D Patel
-
+
OA11.02 - Changes of Brain Structure in Advanced NSCLC Patients Receiving EGFR-TKIs: Dynamic Analysis Based on Series MRI Images
14:10 - 14:20 | Presenter: Chunli Luo | Author(s): Beisheng Yang, Xiaojuan Zhou, Lin Zhou, Ying Zhou, Jiang Zhu, Meijuan Huang, Feng Peng, Yongmei Liu, Yongsheng Wang, Zhiping Li, You Lu, Su Lui, Youling Gong
- Abstract
Loading...